Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Regulatory News (AVO)

  • There is currently no data for AVO

Acquisition

11 Dec 2006 07:01

CareCapital Group plc11 December 2006 For release at 0700h, 11 December 2006 CareCapital Group Plc ("CareCapital" or "the Company") Investment and Development Programme in Germany CareCapital Group Plc, the healthcare real estate company which listed on AIM inAugust (CARE), announces that it has completed the acquisition of a majormedical centre in Berlin as the first part of an initial €35 million investmentand development programme in Germany. This first investment, at an acquisition cost of • 9.2 million, is a 4,100 sq mmedical facility housing 34 tenants including physicians, dentists, a dentallab, diagnostic facilities, a pharmacy and other healthcare related retailers.An additional €4.2 million acquisition of a 2,800 sq m medical centre housing 25medical tenants situated to the South East of Berlin together with its adjoiningdevelopment site is scheduled for completion in February 2007. These two investments represent the initial stage of the €35 million programme,on which heads of terms have been agreed with a German developer/constructioncompany, with funding supplied by a major German bank. The programme currentlyincludes two further development sites in the Berlin area. Any additionalfunding for the programme will come from the Company's existing resources andfacilities. The programme enables CareCapital to capitalise on recent changes in Germanlegislation which favour primary care provision from large, integrated medicalcare centres. Michael Sinclair, Chairman, commented: "The investment and development programmein Germany follows extensive research, conducted by CareCapital over the pastmonths and represents an exciting opportunity for the Company. It will notimpact on our development programme in the UK which remains on target. "CareCapital will leverage its UK experience to manage and develop the mixedeconomy healthcare facilities in Germany that will increasingly become a featureof UK primary care provision as services are moved out of the hospitalenvironment to community locations in accordance with Government policy. Inaddition, the programme will bring us high quality assets at yieldssignificantly greater than those currently prevailing in the UK and withsimilarly comparable covenant profiles." For further information please visit www.carecapital.co.uk or contact: CareCapital Group Plc Daniel Stewart & Co. Plc Tavistock CommunicationsPaul Stacey, Managing Director Lindsay Mair, Director - Simon Hudson,Shareen Courtney, Marketing Corporate Finance Richard SunderlandTel: 020 7034 1949 Tel: 020 7776 6550 Tel: 020 7920 3150pstacey@carecapital.co.uk lindsay.mair@danielstewart.co.uk shudson@tavistock.co.ukscourtney@carecapital.co.uk rsunderland@tavistock.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th May 20247:00 amRNSCancellation - Advanced Oncotherapy Plc
3rd May 20248:54 amRNSFurther update on financing discussions
2nd Apr 20243:50 pmRNSFurther update on financing discussions
29th Feb 20245:19 pmRNSFurther update on financing discussions
1st Feb 20247:00 amRNSFurther update on financing discussions
9th Jan 20249:00 amRNSUpdate on Financing Discussions
23rd Oct 20237:00 amRNSUpdate on Financing and Current Financial Position
17th Jul 20237:00 amRNSRecapitalisation and funding plan, update on FSP
30th Jun 20235:00 pmRNSTotal Voting Rights
30th Jun 20237:30 amRNSSuspension - Advanced Oncotherapy PLC
30th Jun 20237:15 amRNSUpdate on financing, suspension of trading on AIM
29th Jun 20231:35 pmRNSHolding(s) in Company
29th Jun 20239:59 amRNSForm 8.3 - Advanced Oncotherapy PLC
28th Jun 202310:25 amRNSForm 8.3 - Advanced Oncotherapy PLC
27th Jun 202310:29 amRNSForm 8.3 - Advanced Oncotherapy
27th Jun 202310:25 amRNSForm 8.3 - Advanced Oncotherapy
26th Jun 20234:26 pmRNSForm 8.3 - Advanced Oncotherapy
26th Jun 202310:57 amRNSPartial conversion of Convertible Notes
23rd Jun 202311:05 amRNSHolding(s) in Company
23rd Jun 20239:30 amRNSForm 8.3 - Advanced Oncotherapy PLC
20th Jun 20235:28 pmRNSHolding(s) in Company
19th Jun 20235:56 pmRNSPartial conversion of Convertible Notes
19th Jun 20231:48 pmRNSForm 8.3 - Advanced Oncotherapy PLC
16th Jun 20236:23 pmRNSIssue of warrants
13th Jun 202311:46 amRNSForm 8.3 - Advanced Oncotherapy PLC
31st May 20235:57 pmRNSUpdate on financing and convertible notes
30th May 202310:42 amRNSForm 8.3 - Advanced Oncotherapy Plc
24th May 20235:54 pmRNSForm 8 (OPD) Advanced Oncotherapy plc
24th May 20235:29 pmRNSForm 8.3 - Advanced Oncotherapy - Cosylab d.d.
22nd May 20232:59 pmRNSForm 8.3 - Advanced Oncotherapy plc
19th May 202312:09 pmRNSForm 8.3 - Advanced Oncotherapy PLC
17th May 20232:58 pmRNSForm 8.3 - Advanced Oncotherapy plc
15th May 202311:36 amRNSUpdate on Convertible Note & Loan Extension
15th May 20239:19 amRNSForm 8.3 - Advanced Oncotherapy Plc
12th May 202312:53 pmRNSForm 8.3 - Advanced Oncotherapy - Minmetco Limited
11th May 20235:14 pmRNSForm 8.3 - Advanced Oncotherapy - eQ Blue Planet
11th May 202311:17 amRNSForm 8.3 - Advanced Oncotherapy - Atlantic Cedar
10th May 202311:34 amRNSForm 8.3 - Advanced Oncotherapy plc
9th May 20234:40 pmRNSForm 8.3 - Advanced Oncotherapy - Baltisches Haus
9th May 20234:37 pmRNSForm 8.3 - Advanced Oncotherapy plc
9th May 20234:36 pmRNSForm 8.3 - Advanced Oncotherapy plc
5th May 20238:56 amRNSFORM 8.3 - Advanced Oncotherapy
5th May 20237:00 amRNSAdditional funding from Secured Convertible Note
4th May 20235:01 pmRNSForm 8.3 - Advanced Oncotherapy Plc
4th May 20233:55 pmRNSChange of Registered Office
3rd May 20236:19 pmRNSRule 2.9 Announcement
3rd May 20234:28 pmRNSForm 8.3 - Advanced Oncotherapy PLC
2nd May 20236:19 pmRNSForm 8 (OPD) Advanced Oncotherapy plc
18th Apr 20237:00 amRNSStrategic review and formal sale process
31st Mar 20236:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.